Fagron Expands Market Reach with Key Acquisitions in North America and Brazil

Fagron SA ( (GB:0HNZ) ) has provided an update.

Fagron has announced strategic acquisitions of CareFirst Specialty Pharmacy in North America and Injeplast in Brazil, with a combined value of approximately €30 million. These acquisitions are in line with Fagron’s strategy to expand in key markets and are expected to enhance its market presence in both the North American and Latin American regions. CareFirst will bolster Fagron’s reach in the North American prevention and lifestyle markets, while Injeplast will support its Essentials strategy by expanding the product portfolio and customer base in Latin America, ultimately strengthening Fagron’s global operations.

More about Fagron SA

Fagron is a globally recognized leader in pharmaceutical preparations, offering personalized pharmaceutical care solutions to hospitals, pharmacies, clinics, and patients across over 30 countries. Fagron NV is based in Nazareth, Belgium, and trades on Euronext Brussels and Amsterdam. Its operational activities are managed by Fagron BV, headquartered in Rotterdam, Netherlands.

YTD Price Performance: -0.02%

Average Trading Volume: 8,068

Technical Sentiment Consensus Rating: Buy

Current Market Cap: €1.21B

Find detailed analytics on 0HNZ stock on TipRanks’ Stock Analysis page.